Author: Vivian Xie 30th April 2026

It feels like only yesterday that artificial intelligence (AI) started creeping into pharma industry conversations as little more than a buzzword. But in just a few short years, it’s become the force transforming innovation, efficiency, and growth. From accelerating drug discovery to optimising manufacturing processes, AI is reshaping the way the industry operates.

At CPHI Milan, Europe’s biggest pharma industry gathering, the new AI & Tech Zone will showcase how these cutting-edge technologies are moving beyond theoretical applications to deliver real-world impact. Here, we’ll explore how AI is revolutionising the pharmaceutical industry and demonstrate how the innovations featured at CPHI Milan’s AI & Tech Zone can help attendees with technology providers offering practical solutions.

The Role of AI in the Pharmaceutical Industry

The pharma industry has quickly found applications for artificial intelligence across the entire value chain. From research and development (R&D) to manufacturing and supply chain management, AI is enabling companies to overcome long-established challenges and unlock new opportunities.

1. Accelerating Drug Discovery

Traditional drug development is a time-consuming and costly process, and it often takes many years and billions of euros to bring a single drug to market. AI is changing this paradigm by enabling researchers to analyse vast datasets, identify potential drug candidates, and predict their efficacy with unprecedented speed and accuracy. From small molecule prediction to protein structure modelling, the use of AI in drug discovery is set to increase as more biological datasets are produced and used to train AI models. [1]

 This specialism is becoming big business in itself, and competition between the main AI drug discovery companies [2] is leading to major breakthroughs and significant mergers. For example, when Exscientia joined forces with Recursion in 2024, it ushered in what Pharma Phorum described as ‘a new phase of platform consolidation’ which bodes for a bright future for the drug development sector.

2. Optimising Pharmaceutical Manufacturing

AI is also transforming pharmaceutical manufacturing by improving efficiency, precision and scalability. Through manufacturing automation, companies can monitor their production processes in real time, allowing them to predict equipment failures and optimise their resource utilisation.

AI is ushering in a new way of working with digitised manufacturing with Pharma 5.0. This new industrial wave explores not only how AI can bolster pharmaceutical manufacturing workflows, but also how these process optimisations ultimately benefit the industry workforce and, ultimately, patients. [3]

3. Enhancing Supply Chain Management

The complex, highly regulated nature of the pharmaceutical supply chain make it a prime candidate for optimisation, and AI technologies have a great deal to offer. For example, they can enhance visibility at all points of the process, predict disruptions and improve inventory management. All of this goes to ensure that products reach patients on time and in compliance with regulatory standards.

What to Expect at CPHI Milan’s AI & Tech Zone

The AI & Tech Zone at CPHI Milan is a must-visit for anyone looking to stay ahead of the curve in pharma technology trends. This dedicated area will spotlight cutting-edge innovations, expert insights, and networking opportunities, providing attendees with a comprehensive overview of how AI is transforming the industry.

1. Showcasing Real-World Applications

The AI & Tech Zone will highlight practical applications of artificial intelligence across the pharmaceutical value chain. From AI drug discovery platforms to manufacturing automation solutions, attendees will have the opportunity to explore technologies that are already delivering measurable results. From identifying novel compounds to streamlining processes, you’ll be able to see for yourself what the next generation of pharma will look like in practice.

2. Expert Insights and Panel Discussions

In addition to technology showcases, the AI & Tech Zone will feature panel discussions and presentations from industry leaders. These sessions will cover topics such as:

 The future of AI in pharmaceutical industry Best practices for implementing AI in drug development and manufacturing Strategies for overcoming challenges in AI adoption 

Attendees can gain valuable insights from experts at the forefront of AI innovation, helping them navigate the complexities of integrating these technologies into their operations.

3. Networking Opportunities

The AI & Tech Zone is also a hub for networking, connecting attendees with technology providers, researchers, and industry peers. Whether you’re looking to partner with an AI solutions provider or learn from others’ experiences, this zone offers a unique platform for collaboration and knowledge sharing.

The Benefits of AI for the Pharmaceutical Industry

The adoption of AI offers numerous benefits for the pharmaceutical industry, enabling companies to address long-standing challenges and seize new opportunities.

1. Improved Efficiency and Cost Savings

AI technologies streamline processes, reduce waste, and optimise resource utilisation, leading to significant cost savings. For example, AI-driven automation in manufacturing can reduce production costs by minimising errors and downtime.

2. Faster Time-to-Market

By accelerating drug discovery and development, AI enables companies to bring new treatments to market more quickly. This is particularly important in the context of addressing unmet medical needs, where speed can save lives.

3. Enhanced Quality and Compliance

AI-powered quality control systems ensure that products meet the highest standards of safety and efficacy. These systems also support pharmaceutical regulatory compliance strategies by automating documentation and monitoring processes.

4. Greater Supply Chain Resilience

AI enhances supply chain visibility and agility, enabling companies to respond more effectively to disruptions and mitigate any damage to other parts of the supply chain elsewhere.

Overcoming Challenges in AI Adoption

While the benefits of AI are clear, implementing these technologies is not without issues.

1. Ensuring Data Quality and Integration

AI systems rely on high-quality data to deliver accurate insights. Companies must invest in data management and integration solutions to ensure that their tools have access to reliable and comprehensive datasets.

2. Navigating Regulatory Requirements

Regulatory compliance is a critical consideration in AI adoption. Companies must ensure that their AI systems meet the requirements of agencies such as the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA).

3. Building Workforce Capabilities

Implementing AI requires a skilled workforce capable of managing and leveraging these technologies. Companies must invest in training and education to equip their employees with the necessary skills to integrate AI into their day-to-day practices.

The Future of Integrated Pharma Regulatory Compliance

As the pharmaceutical industry continues to evolve, integrated strategies will remain integral to supporting a resilient supply chain – only if  regulatory compliance and quality assurance are maintained. Advances in technology such as AI and blockchain will provide further aid for companies seeking to standardize their value chain and follow regulatory guidance.

At the same time, the increasing complexity of global regulations will require companies to adopt more proactive and collaborative approaches to ensure their work is compliant with all international standards. By embracing integration and innovation, pharmaceutical businesses can navigate these challenges and continue to deliver safe and effective products to patients worldwide.